Home China Rejects Gilead's Sovaldi Patent Application
 

Keywords :   


China Rejects Gilead's Sovaldi Patent Application

2015-06-21 11:47:21| Biotech - Topix.net

China's State Intellectual Property Office has decided to reject a Gilead Sciences, Inc. 's patent application relating to its hepatitis C drug sofosbuvir, marketed as Sovaldi. The rejection could have important implications for Gilead, its generic drug competitors and HCV patients worldwide.

Tags: china application patent rejects

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
02.11Subtropical Storm Patty Update Statement
02.11Summary for Subtropical Storm Patty (AT2/AL172024)
02.11Atlantic Tropical Weather Outlook
02.11Eastern North Pacific Tropical Weather Outlook
02.11Weekly Recap: Nippon Paint, AkzoNobel, PPG Top This Weeks Stories
02.11Subtropical Storm Patty Graphics
02.11Subtropical Storm Patty Forecast Discussion Number 1
02.11Subtropical Storm Patty Wind Speed Probabilities Number 1
More »